DICE Therapeutics, Inc.
DICEDelisted Aug 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645569
DICE Therapeutics, Inc. was delisted on Aug 9, 2023; its insiders filed their last Form 4 on Aug 9, 2023; 160 institutions reported holding it in 13F filings for Q2 2023, worth $2.12B in total; Fairfax Financial was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding DICE Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 160 | 1 | 0 | −159 |
| Shares | 45.6M | 17.6K | 0 | −45.6M (−100.0%) |
| Value | $2.12B | $816.3K | $0 | −$2.11B (−100.0%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held DICE Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (159)
Institutions that held DICE Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
Showing the largest 100 of 159 by value.
Not filed for Q3 2023 yet (1)
Institutions that held DICE Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 17,570 | $816.3K |